Skip to nav Skip to content

News Releases and Statements

Facebook Twitter LinkedIn Email

Infectious Diseases Experts Honored for Outstanding Work in Patient Care, Research, Public Health and Education

Among the nine exceptional individuals being recognized by the Infectious Diseases Society of America, James D. Cherry, M.D., FIDSA, has been honored with this year’s Alexander Fleming Award for lifetime achievement. IDSA is pleased to acknowledge the following individuals for excellence in the field of infectious diseases with its annual Society Awards:

IDSA Releases Guideline for Diagnosis and Management of Babesiosis

A new evidence-based clinical practice guideline for the prevention, diagnosis and treatment of the worldwide disease caused by Babesia parasites has been published in Clinical Infectious Diseases. Providing current standards of diagnosis and management of human babesiosis, the 2020 Guideline on Diagnosis and Management of Babesiosis was developed by a multidisciplinary panel convened by IDSA.

IDSA, AAN, and ACR Release Guidelines for Prevention, Diagnosis, and Treatment of Lyme Disease

New evidence-based clinical practice guidelines for the prevention, diagnosis, and treatment of Lyme disease have been developed by a multidisciplinary panel led by the IDSA, the American Academy of Neurology, and the American College of Rheumatology. Representatives from an additional 12 medical specialties and patients also served on the panel.

Barbara D. Alexander, M.D., MHS, FIDSA – President, Infectious Diseases Society of America on CDC’s Advisory Committee on Immunization Practices’ Ethical Principles for Allocating Initial Supplies of COVID-19 Vaccine:

The four principles established by CDC’s Advisory Committee on Immunization Practices’ Ethical Principles for Allocating Initial Supplies of COVID-19 Vaccine set a positive course for mitigating and containing the impacts of the pandemic.

IDSA Response to Pfizer Request for COVID-19 Vaccine EUA

Barbara D. Alexander, M.D., MHS, FIDSA – President, Infectious Diseases Society of America on today’s Pfizer/BioNTech application for Emergency Use Authorization of its COVID-19 vaccine candidate

This Holiday Season Can Stand as a Turning Point in Our Nation’s Control of the COVID-19 Pandemic

With numbers of infections, illnesses, hospitalizations and deaths caused by COVID-19 at record highs as this holiday season begins, the risks posed by the spread of the coronavirus are more dangerous than at any time since its emergence last December.

Seven Institutions Receive the IDSA Antimicrobial Stewardship Center of Excellence Designation

IDSA awarded seven institutions the designation of Antimicrobial Stewardship Center of Excellence. The designated hospitals have created stewardship programs led by infectious diseases-trained physicians and pharmacists that advance science in antimicrobial resistance.

IDSA Provides Feedback to Strengthen FDA Concept Paper on Ranking Antimicrobial Drugs

Cornelius J. Clancy, M.D., member of the Infectious Diseases Society of America’s Antimicrobial Resistance Committee, presented on behalf of IDSA at today’s Food and Drug Administration public meeting to provide feedback on an FDA concept paper regarding the ranking of antimicrobial drugs according to their importance

Statement on the Emergency Use Authorization of Bamlanivimab

We share and appreciate the urgency in expanding therapeutic options for COVID-19 as daily case counts and hospitalization rates reach record levels. For new therapeutics to be used widely and routinely outside of clinical trials, we urge that there be sufficient safety and efficacy data to be confident regarding their use.

IDSA and HIVMA Congratulate the President-elect, Offer Guidance on Pandemic Response

The Infectious Diseases Society of America and its HIV Medicine Association have reached out today to President-elect Joe Biden to congratulate him and to offer their memberships’ expertise as the new administration takes on the challenges of the COVID-19 pandemic and other infectious diseases threats.

IDSA and HIVMA Release New Comprehensive Primary Care Guidance for People with HIV

New guidance published today by an expert panel of the HIV Medicine Association of the Infectious Diseases Society of America updates the 2013 guideline for providing comprehensive evidence-based primary care to people with HIV.

In Comments to DHS, Medical Societies Say Proposed Visa Rule for Physicians Will Exacerbate Our Disease Response Challenges

The Infectious Diseases Society of America, HIV Medicine Association, Pediatric Diseases Society and the Society of Healthcare Epidemiology of America have called on the Department of Homeland Security to exempt physicians working in the United States on J-1 visas from the agency’s proposed rule

This website uses cookies

We use cookies to ensure that we give you the best experience on our website. Cookies facilitate the functioning of this site including a member login and personalized experience. Cookies are also used to generate analytics to improve this site as well as enable social media functionality.